Cystamine slows but not inverses the progression of monocrotaline-induced pulmonary arterial hypertension in rats

Effects of ovariectomy on antioxidant defence systems in the right ventricle of female rats with pulmonary arterial hypertension induced by monocrotaline

(2018) Rafaela Siqueira et al.   CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY

Epigallocatechin-3-gallate ameliorates hypoxia-induced pulmonary vascular remodeling by promoting mitofusin-2-mediated mitochondrial fusion

(2017) Tian-Tian Zhu et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Targeting Vascular Remodeling to Treat Pulmonary Arterial Hypertension

(2017) A.A. Roger Thompson et al.   TRENDS IN MOLECULAR MEDICINE

Tissue Transglutaminase Modulates Vascular Stiffness and Function Through Crosslinking‐Dependent and Crosslinking‐Independent Functions

(2017) Jochen Steppan et al.   Journal of the American Heart Association

Involvement of transglutaminase 2 and voltage-gated potassium channels in cystamine vasodilatation in rat mesenteric small arteries

(2016) Morten Engholm et al.   BRITISH JOURNAL OF PHARMACOLOGY

Nebivolol has a beneficial effect in monocrotaline-induced pulmonary hypertension

(2016) Edward A. Pankey et al.   CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY

Regulation of allergic lung inflammation by endothelial cell transglutaminase 2

(2015) Frank Soveg et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Peroxisome proliferator-activated receptor γ attenuates serotonin-induced pulmonary artery smooth muscle cell proliferation and apoptosis inhibition involving ERK1/2 pathway

(2015) Xinyuan Han et al.   MICROVASCULAR RESEARCH

Lipopolysaccharide-Stimulated Transglutaminase 2 Expression Enhances Endocytosis Activity in the Mouse Microglial Cell Line BV-2

(2015) Kenji Kawabe et al.   NEUROIMMUNOMODULATION

Role of hypoxia-induced transglutaminase 2 in pulmonary artery smooth muscle cell proliferation

(2014) Krishna C. Penumatsa et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Tissue transglutaminase promotes serotonin-induced AKT signaling and mitogenesis in pulmonary vascular smooth muscle cells

(2014) Krishna Penumatsa et al.   CELLULAR SIGNALLING

Elevated Transglutaminase 2 Activity Is Associated with Hypoxia-Induced Experimental Pulmonary Hypertension in Mice

(2013) Thomas R. DiRaimondo et al.   ACS Chemical Biology

Targeting the serotonin pathway for the treatment of pulmonary arterial hypertension

(2013) Matthew Thomas et al.   PHARMACOLOGY & THERAPEUTICS

Serotonylated fibronectin is elevated in pulmonary hypertension

(2012) Lin Wei et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Fluoxetine inhibits monocrotaline-induced pulmonary arterial remodeling involved in inhibition of RhoA–Rho kinase and Akt signalling pathways in rats

(2012) Han-Ming Wang et al.   CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY

Novel roles for biogenic monoamines: from monoamines in transglutaminase-mediated post-translational protein modification to monoaminylation deregulation diseases

(2011) Diego J. Walther et al.   FEBS Journal

Pressure Load: The Main Factor for Altered Gene Expression in Right Ventricular Hypertrophy in Chronic Hypoxic Rats

(2011) Jonas D. Baandrup et al.   PLoS One

The Redox State of Transglutaminase 2 Controls Arterial Remodeling

(2011) Jeroen van den Akker et al.   PLoS One

RhoA and Rho Kinase Activation in Human Pulmonary Hypertension

(2009) Christophe Guilluy et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

CONTINUOUS FLUOXETINE ADMINISTRATION PREVENTS RECURRENCE OF PULMONARY ARTERIAL HYPERTENSION AND PROLONGS SURVIVAL IN RATS

(2009) Shao-Ping Zhu et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Involvement of Tissue Transglutaminase in Endothelin 1–Induced Hypertrophy in Cultured Neonatal Rat Cardiomyocytes

(2009) Xin Li et al.   HYPERTENSION